CureVac N.V.
CVAC · NASDAQ
11/24/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1 | $1 | $1 |
| - Cash | – | $0 | $0 | $0 |
| + Debt | – | $0 | $0 | $0 |
| Enterprise Value | – | $1 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 39,570.8% | 39.4% | -93.8% | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 95.8% | -77.8% | 2% | 89.7% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 0% | -4,417.1% | -5,234.6% | -241.2% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 68.4% | -4,783.9% | -5,832.5% | -226.4% |
| EPS Diluted | 1.5 | -0.26 | -0.23 | -0.15 |
| % Growth | 676.9% | -13% | -53.3% | – |
| Operating Cash Flow | – | -$0 | -$0 | -$0 |
| Capital Expenditures | – | -$0 | -$0 | -$0 |
| Free Cash Flow | – | -$0 | -$0 | -$0 |